FP7Individual fellowship2012–2014

VB · VASCULAR BONE

FP7 — People (Marie Curie Actions)

Duration
2012-02-13 → 2014-02-12
EU contribution
€209,593
Participants
1
Scheme
MC-IEF

Lines connect the coordinator with its partners.

Results in brief

VASCULAR BONE

The European population is ageing and as a result the number of bone-related fractures is increasing as well. After a bone fracture, healing starts immediately and angiogenesis, the formation of new blood vessels from previous ones, is the first and a critical step in this regeneration process. Non or non-delayed union fractures often require the implant of a synthetic bone substitute; however commercially available bone substitutes are mainly osteoconductive, and their pro-angiogenic potential although critical for bone healing is still overlooked. Angiogenesis is a multistep process regulated by chemical and mechanical factors. The most well studied mechanical factor is shear stress induced by the blood flow. Increased blood flow is known to augment blood vessels diameter and stimulate angiogenesis. Extracellular stiffness is a very important mechanical factor as well, involved in many cellular events e.g. stem cell differentiation; however their influence in the angiogenic process remains unclear. The present proposal aims to enlarge our fundamental knowledge on stiffness and angiogenesis in order to rationally develop a pro-angiogenic bone substitute. Angiogenesis encompass cell migration, release of lytic proteins, e.g. matrix metalloproteinases, release of growth factors and tube formation. This project investigated he metabolic activity, gene and protein expression, protein and lipid chemical signature and tube formation of endothelial cells (ECs) exposed to low and high stiffness substrates, with the stiffer substrate matching bone rigidity. The paracrine effect of endothelial cells exposed to different rigidities on human mesenchymal stem cell (hMSC) differentiation into osteoblast-like cells was studied using a co-culture system without direct cell to cell contact. ECs were cultured on polyacrylamide gels coated with collagen I of different stiffnesses fitted on the bottom of a 12-well tissue culture plate and hMSCs were cultured on a polysterene insert also coated with collagen I fitted on top of the well. This project has delivered very well on its anticipated outputs. The most striking results is that stiffness modulates protein activity e.g. β-catenin and as well as growth factors expression. To conclude our understanding regarding the role of extracellular stiffness on angiogenesis was significantly enlarged. This knowledge will contribute for the rationale development of bone specific regenerative approaches, resulting in better and more effective treatments, with being elder people the main target of such benefits.

Data: CORDIS, © European Union

Project objective

AbstractThe European population is ageing, forecasting a growing demand of health care solutions. The demand for biomaterials, either for orthopaedics, dental or maxilla-facial applications, will follow this trend. According to Biomet report, it is estimated that in Europe, 180,000 man and 610,000 women will suffer from hip fracture due to osteoporosis. These numbers will grow until 2050. Bearing in mind European population ageing as well as the status of social and financial indicators, it is urgent to develop more successful bone substitutes. A large number of bone substitutes made of calcium phosphate-based materials are commercially available. Despite the progresses that have been made with regard to their biocompatibility, one research area is being serious neglected: the study of the capability of acquiring blood vessels (angiogenic capability). The presence of blood vessels is the first critical step of bone regeneration and affects the implant success rate. The present proposal aims to tackle this problem through the development of a bone substitute with angiogenic potential, the VASCULAR BONE.""

Original text from CORDIS.

Participants

  • IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE · LondonCoordinatorUnited Kingdom

Links

Data: CORDIS, © European Union